share_log

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA將參加於10月16日週三舉行的2024年Maxim Healthcare虛擬峯會
Accesswire ·  10/15 10:30

STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit from October 15th to 17th.

2024年10月15日,紐約斯托尼布魯克/ACCESSWIRE/ applied dna sciences股份有限公司(納斯達克股票代碼:APDN)("應用DNA"),一家PCR基因技術領軍企業,今天宣佈,首席執行官詹姆斯·A·海沃德博士將參加2024麥斯姆保健虛擬峯會上的爐邊聊天。麥斯姆集團LLC將於10月15日至17日舉辦此虛擬峯會。

Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research, will interview Dr. Hayward.Applied DNA's fireside chat will be available for viewing by registered conference attendees on Wednesday, October 16, 2024.

麥斯姆生物技術研究負責人,具有博士學位的詹森·麥卡錫將採訪海沃德博士。應用DNA的爐邊聊天將於2024年10月16日星期三提供給註冊參會者觀看。

Details for the fireside chat are as follows:
Date: Wednesday, October 16, 2024
Time: 12:50 p.m. EDT
Presenter: James A. Hayward, president and chief executive officer of Applied DNA
Registration: link

爐邊聊天詳情如下:
日期: 2024年10月16日,星期三
時間:下午12:50 EDT
演講者:詹姆斯·A·海沃德,應用DNA總裁兼首席執行官
註冊:鏈接

About Applied DNA Sciences

關於Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

applied dna sciences是一家生物技術公司,開發技術用於生產和檢測脫氧核糖核酸("DNA")。利用聚合酶鏈反應("PCR")實現DNA的生產和檢測,我們在三個主要業務市場運營:(i)在合成DNA的酶法制造方面用於核酸類治療藥物的生產,並開發和銷售用於mRNA治療藥物生產的專有RNA聚合酶("RNAP");(ii)在分子診斷和遺傳檢測服務中檢測DNA和RNA;以及(iii)用於工業供應鏈安全服務的DNA的製造和檢測。

Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.

請訪問adnas.com了解更多信息。關注我們的X和領英。加入我們的郵件列表。

Contacts:

聯繫人:

Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web:
X: @APDN

投資者關係聯繫人:Sanjay M. Hurry,917-733-5573,sanjay.hurry@adnas.com
網站:
X:@APDN

SOURCE: Applied DNA Sciences

來源:applied dna sciences


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論